Stock Report

Download full stock data and analysis for free Last Updated: 30-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Kronox Lab Sciences Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: KRONOX | BSE: 544187

₹179.59

up-down-arrow ₹-8.67 (-4.61%)

As on 28-Aug-2026IST

Market cap

info icon

₹664 Cr

Revenue (TTM)

info icon

₹105 Cr

P/E Ratio

info icon

23.2

P/B Ratio

info icon

5.4

Div. Yield

info icon

0.3 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 8.65 16.88 6.07 1.93 10.14
EBIT -3.55 12.92 5.25 16.82 20.23
Net Profit -8.74 16.31 11.61 19.03 23.24
EPS -8.73 16.31 11.61 19.03 24.50
Book Value -- -- 28.88 37.42 35.44
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 31.2027.2431.4231.8331.68
Net Margin info 24.7121.4625.7525.9924.79
Return on equity info 32.6135.3926.2726.8232.56
Return on Capital info 43.7847.66--36.0043.82
Return on Assets info 29.2329.2925.2424.5329.61
Debt to Equity (x) info ----0.010.010.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
--
36.00
43.82
51.52
51.63
Peer Median
--
11.47
12.06
13.53
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

26.27

Higher than Peers by 16.79

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
26.27
26.82
32.56
38.45
38.55
Peer Median
9.48
8.78
8.91
10.80
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

25.24

Higher than Peers by 19.00

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
25.24
24.53
29.61
33.54
29.73
Peer Median
6.24
5.45
5.64
6.79
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

31.42

Higher than Peers by 22.55

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
31.42
31.83
31.68
30.08
21.15
Peer Median
8.87
10.64
8.43
8.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

25.75

Higher than Peers by 19.20

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
25.75
25.99
24.79
23.35
16.82
Peer Median
6.55
6.16
5.96
6.62
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
0.00
29.35
26.80
25.19
18.73
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

6.07

Lower than Peers by 0.01

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
6.07
1.02
11.50
-5.98
16.21
Peer Median
6.09
11.13
9.42
9.36
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

5.25

Higher than Peers by 4.31

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
5.25
1.50
17.45
33.71
14.42
Peer Median
0.94
14.08
1.79
-1.67
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

11.61

Higher than Peers by 9.49

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
11.61
8.61
19.28
30.17
20.37
Peer Median
2.12
20.17
-1.10
4.91
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

11.61

Higher than Peers by 9.74

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
11.61
8.61
19.28
30.16
26.66
Peer Median
1.88
14.82
0.15
4.91
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
--
28.88
35.89
48.16
10.90
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.01

Lower than Peers by 0.02

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
0.01
0.01
--
--
--
Peer Median
0.03
0.20
0.16
0.08
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

7.60

Higher than Peers by 5.54

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
7.60
7.60
7.28
6.07
3.82
Peer Median
2.07
1.86
2.23
2.18
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

6.80

Higher than Peers by 5.35

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
6.80
6.80
6.55
4.87
2.80
Peer Median
1.45
1.58
1.96
1.71
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

263.30

Higher than Peers by 254.45

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
263.30
328.21
--
--
237.24
Peer Median
8.85
6.65
8.85
10.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

20.12

Higher than Peers by 1.50

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
20.12
20.93
19.85
19.64
19.41
Peer Median
18.61
19.90
18.32
17.58
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.93

Higher than Peers by 0.13

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
0.93
0.90
1.16
1.41
1.73
Peer Median
0.80
0.89
0.84
0.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
--
74.05
68.37
73.51
84.69
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
--
26.58
28.46
37.42
31.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
--
54.30
50.41
56.53
64.28
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
--
46.33
46.42
54.40
52.26
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

23.23

Lower than Peers by 13.69

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
23.23
13.09
20.96
--
--
Peer Median
36.92
36.92
35.43
34.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

5.38

Higher than Peers by 2.58

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
5.38
3.12
5.92
--
--
Peer Median
2.79
3.15
2.26
2.74
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.28

Higher than Peers by 0.01

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
0.28
0.51
0.35
--
--
Peer Median
0.27
0.23
0.30
0.28
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

15.11

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
15.11
7.98
13.94
1.12
1.42
Peer Median
--
28.11
23.67
19.92
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

664

Lower than Peers by 2,005

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Kronox Lab Sciences
664
362
534
--
--
Peer Median
2,669
1,815
920
1,568
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...